2 weeks ago

Lord’s Mark Plans Healthcare Expansion, Revenue Growth and Energy Demerger

Lord’s Mark Plans Healthcare Expansion, Revenue Growth and Energy Demerger
Lord's Mark Industries outlines expansion across healthcare and oncology; projects ₹1,550 crore revenue in FY2027 · livemint.com

Lord’s Mark is a company that works in healthcare, diagnostics, technology and renewable energy.

It expects to earn at least ₹1,550 crore in revenue during FY2027.

It also expects to make at least ₹178 crore in profit after tax.

The company wants to separate its renewable energy and LED business into another company.

It plans to bring CAR-T cancer treatment to India through five centres.

It also plans to open oncology hospitals in smaller cities and 50 dialysis centres across India.

The company says these projects could help more patients receive medical care.

It is also setting up businesses in the UK and Switzerland to sell Indian-made diagnostic products.

The company says its genomic testing and medical software products have reached important development milestones.

Key facts

FY2027 revenue projection
At least ₹1,550 crore, representing more than 20% growth compared with FY2026.
FY2027 PAT projection
At least ₹178 crore, with a projected 11.4% margin.
Proposed energy demerger
The Renewable Energy and LED business would be separated into Lords Shakti Power Limited by March 2027.
CAR-T rollout
An exclusive agreement is planned to bring CAR-T cell therapy to India across five centres, beginning with Mumbai and Bangalore.
Oncology hospitals
Two planned 70-bed pilot hospitals in Vapi and Solapur would be supported by a proposed ₹200 crore debt raise.
Dialysis expansion
The company plans to establish 50 company-operated dialysis centres across India by March 2027.
International subsidiaries
Lords Mark Industries UK Limited has been incorporated, and Lords Mark Industries Swiss Limited is being established.

Quotes

Sachidanand Upadhyay, Managing Director, Lord's Mark Industries Ltd.

Managing Director of Lord's Mark Industries

“"The guidance we have issued reflects the strength of our existing operations, with top‑line growth of at least 20% and PAT growth of at least 50%. The subsequent announcements are what we build on top of them: cancer care reaching India's rural districts, advanced CAR‑T therapy at affordable prices for Indian patients, and Indian‑made diagnostics serving laboratories from the UK to Switzerland."”
livemint.com
“"Lord's Mark today stands at the most important inflection point in its history. Over the past decade we have built profitable, scaled businesses in diagnostics and renewable energy, the foundations of which now fund our next chapter."”
livemint.com

Sources

Related news